Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The treatment of cancer associated thrombosis: does one size fit all? Who should get LMWH/warfarin/DOACs?

Noble S, Sui J.

Thromb Res. 2016 Apr;140 Suppl 1:S154-9. doi: 10.1016/S0049-3848(16)30115-3.

PMID:
27067970
2.

Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.

Pruemer J.

Semin Oncol. 2006 Apr;33(2 Suppl 4):S26-39; quiz S41-2. Review.

PMID:
16638458
3.

Considerations and challenges with existing treatments for thrombosis in cancer patients.

Schwartz RN.

Am J Health Syst Pharm. 2005 Nov 15;62(22 Suppl 5):S7-9.

PMID:
16286367
4.

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.

Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, Khorana AA; CATCH Investigators.

BMC Cancer. 2013 Jun 13;13:284. doi: 10.1186/1471-2407-13-284.

6.

[Long-term treatment of venous thromboembolism in patients with cancer].

Šmrha J, Kessler P, Poul H, Harudová M.

Vnitr Lek. Summer 2016;62(6):449-52. Czech.

PMID:
27485842
7.

Trousseau's syndrome: cancer-associated thrombosis.

Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K.

Jpn J Clin Oncol. 2016 Mar;46(3):204-8. doi: 10.1093/jjco/hyv165. Epub 2015 Nov 6. Review.

PMID:
26546690
8.

Pathophysiology and management of thrombosis in cancer: 150 years of progress.

Soff GA.

J Thromb Thrombolysis. 2013 Apr;35(3):346-51. doi: 10.1007/s11239-013-0897-9. Review.

PMID:
23440574
9.

Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis.

Connell NT, Abel GA, Connors JM.

Thromb Res. 2017 Feb;150:53-58. doi: 10.1016/j.thromres.2016.12.017. Epub 2016 Dec 22.

PMID:
28039844
10.

Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Semin Thromb Hemost. 2008 Feb;34(1):58-73. doi: 10.1055/s-2008-1066025. Review.

PMID:
18393143
11.

Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.

Nishioka J, Goodin S.

J Oncol Pharm Pract. 2007 Jun;13(2):85-97. Review.

PMID:
17873108
12.

Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.

Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat-Bouvet L, Labourey JL, Martin J, Slaouti P, Tubiana-Mathieu N.

Cancer Chemother Pharmacol. 2013 Jul;72(1):65-73. doi: 10.1007/s00280-013-2169-y. Epub 2013 May 1.

PMID:
23636449
13.

Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.

Huisman MV, Bounameaux H.

Semin Vasc Med. 2005 Aug;5(3):276-84.

PMID:
16123915
14.

Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?

Khorana AA, Yannicelli D, McCrae KR, Milentijevic D, Crivera C, Nelson WW, Schein JR.

Thromb Res. 2016 Sep;145:51-3. doi: 10.1016/j.thromres.2016.07.013. Epub 2016 Jul 26.

PMID:
27485998
15.

Management of thromboembolism in patients with cancer.

Viale PH.

Oncol Nurs Forum. 1999 Nov-Dec;26(10):1625-32; quiz 1633-4. Review.

PMID:
10573679
16.

Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?

Fareed J, Iqbal O, Cunanan J, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Int Angiol. 2008 Jun;27(3):176-92. Review.

PMID:
18506123
17.

LMWH in cancer patients with renal impairment - better than warfarin?

Bauersachs RM.

Thromb Res. 2016 Apr;140 Suppl 1:S160-4. doi: 10.1016/S0049-3848(16)30116-5. Review.

PMID:
27067971
18.

[Thrombosis in spite of warfarin--what should be done?].

Lassila R.

Duodecim. 2001;117(24):2632-6. Review. Finnish. No abstract available.

PMID:
12183826
19.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Candeloro M, De Tursi M, Russi I, Rutjes AW.

Cochrane Database Syst Rev. 2016 Dec 1;12:CD008500. doi: 10.1002/14651858.CD008500.pub4. Review.

20.

Cancer-Associated Thrombosis: Improving Patient Adherence to Low-Molecular-Weight Heparin Therapy.

Chen L.

Clin J Oncol Nurs. 2017 Aug 1;21(4):502-505. doi: 10.1188/17.CJON.502-505.

PMID:
28738034

Supplemental Content

Support Center